Our studies in mice have suggested that the immunological microenvironment of preneoplastic lesions could determine their fate toward neoplasia or regression. A role for gastrointestinal tract bacteria antigens in modulating cancer-related immune responses in the tumor micro-and macro-environment is emerging, thus opening new possibilities for colon cancer prevention.
展开▼
